Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Conditions placed on Evonik-Huber deal

by Marc S. Reisch
June 26, 2017 | A version of this story appeared in Volume 95, Issue 26

The European Commission has approved Evonik Industries’ $630 million purchase of J.M. Huber Corp.’s specialty silica operations, but with conditions. Evonik will have to divest precipitated silica used in dental applications. Huber will have to divest precipitated silica used as a defoamer as well as its hydrophobic precipitated silica business. The commission says the two must sell the businesses, and provide production technology and support, to a firm with an established presence in Europe. Both have agreed to the conditions.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.